Showing results (141-150 of 439) with videos related to

Sort By:
Pageof 44
Cancer Chemotherapy and Pharmacology|November 8, 2008
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib doseMassimo Breccia, Daniela Cilloni, Laura Cannella, et al.
Hematological Oncology|September 4, 2009
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard doseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.
Leukemia Research|June 18, 2011
5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatmentMassimo Breccia, Adriano Salaroli, Giuseppina Loglisci, et al.
Frontiers in Oncology|June 23, 2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combinationChiara Masucci, Mauro Passucci, Emilia Scalzulli, et al.
Leukemia Research|September 11, 2007
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphomaMassimo Breccia, Maurizio Martelli, Laura Cannella, et al.
Leukemia Research|November 9, 2015
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort studyFederico De Angelis, Maria Elena Tosti, Saveria Capria, et al.
Npj Viruses|January 9, 2026
Characterisation of the tilapia lake virus proteome and identification of an 11th protein, S9-F3Nunticha Pankaew, Dominic Kurian, Federico De Angelis, et al.
Clinical Advances in Hematology & Oncology : H&O|December 19, 2019
Treatment-free remission in chronic myeloid leukemiaMatteo Molica, Kiran Naqvi, Jorge E Cortes, et al.
British Journal of Haematology|March 12, 2026
Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort studyAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.
Leukemia Research|November 16, 2004
Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformationMassimo Breccia, Marco Mancini, Mauro Nanni, et al.
Pageof 44